search
for
 About Bioline  All Journals  Testimonials  Membership  News  Donations


Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 100, Num. s1, 2005, pp. 211-215

Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol.100, Suppl. 1, March, 2005, pp. 211-215

Epithelial effects of proteinase-activated receptors in the gastrointestinal tract

Wallace K MacNaughton

Financial support: Canadian Institutes of Health Research
+Corresponding author. E-mail: wmacnaug@ucalgary.ca and Senior Scholar of the Alberta Heritage Foundation for Medical Research

Received 8 November 2004
Accepted 30 Decembert 2004

Code number: oc05053

Mucosal Inflammation Research Group, University of Calgary, 3330 Hospital Dr NW, Calgary, AB T2N 4N1 Canada

The intestinal epithelium plays a crucial role in providing a barrier between the external environment and the internal milieu of the body. A compromised mucosal barrier is characteristic of mucosal inflammation and is a key determinant of the development of intestinal diseases such as Crohn's disease and ulcerative colitis. The intestinal epithelium is regularly exposed to serine proteinases and this exposure is enhanced in numerous disease states. Thus, it is important to understand how proteinase-activated receptors (PARs), which are activated by serine proteinases, can affect intestinal epithelial function. This review surveys the data which demonstrate the wide distribution of PARs, particularly PAR-1 and PAR-2, in the gastrointestinal tract and accessory organs, focusing on the epithelium and those cells which communicate with the epithelium to affect its function. PARs have a role in regulating secretion by epithelia of the salivary glands, stomach, pancreas and intestine. In addition, PARs located on subepithelial nerves, fibroblasts and mast cells have important implications for epithelial function. Recent data outline the importance of the cellular site of PAR expression, as PARs expressed on epithelia may have effects that are countered by PARs expressed on other cell types. Finally, PARs and their ability to promote epithelial cell proliferation are discussed in terms of colon cancer.

Key words: proteinase-activated receptors - epithelium - secretion - inflammation - cancer

The epithelia lining mucosal surfaces are well situated to act as sensors of the external environment, as transducers of luminal stimuli and as effectors of host defense against luminal pathogens. In the case of the gastrointestinal tract, the epithelium must have apical receptors to sense the luminal environment, particularly enteric flora, second messenger systems to relay luminal signals and an array of responses to integrate luminal stimuli with underlying elements including the mucosal immune system, the enteric nervous system and the mucosal and submucosal vascular and lymphatic systems. This capability must be integrated with the epithelium's role in the digestive, absorptive and secretory processes of normal physiological function.

The gastrointestinal epithelium is repeatedly, if not continuously, exposed to an array of proteinases involved in digestion and host defense. The discovery of pro-teinase-activated receptors (PARs) in the gastrointestinal tract suggests, however, that proteinases may act as signaling molecules in addition to their role as agents of protein breakdown. The pharmacology and physiology of PARs have been the subject of recent comprehensive reviews (Macfarlane et al. 2001, Hollenberg & Compton 2002, Ossovskaya & Bunnett 2004). Therefore, this review will focus on PARs expressed on the gastrointestinal epithelium and on cells which interact with the epithelium to regulate its function in health and disease.

DISTRIBUTION OF PARs IN GASTROINTESTINAL TRACT

PARs have been demonstrated in every region of the gastrointestinal tract and accessory organs including the salivary glands (Kawabata et al. 2000a, b), stomach (Nystedt et al. 1995, Kawabata et al. 2001, Kawao et al. 2002), intestine (Kong et al. 1997, Corvera et al. 1997, 1999, Green et al. 2000, Buresi et al. 2003, Seymour et al. 2003), pancreas (Bohm et al. 1996, Kawabata et al. 2002) and liver (Bohm et al. 1996, Fiorucci et al. 2004). The bulk of evidence points toward expression of PAR-1 and PAR-2, although PAR-3 and PAR-4 may also be present (Toyoda et al. 2003, Mule et al. 2004). In all regions of the gastrointestinal tract, PARs are expressed on epithelia and thus are in a position to respond to luminal or mucosal serine pro-teinases. Furthermore, as detailed below, PARs are found on cell types that have been demonstrated to affect epithelial function, including enteric neurons, fibroblasts and immune cells.

EFFECTS OF PARs ON EPITHELIAL FUNCTION

Salivary glands - PAR-2 has been demonstrated by immunohistochemistry to exist on parotid gland acinar epithelium (Kawabata et al. 2002). Activation of PAR-2 has been shown to stimulate the secretion of mucin in a non-cholinergic, non-adrenergic and tyrosine kinase-dependent manner (Kawabata et al. 2000a). In addition, activation of PAR-2 in vivo stimulates the secretion of salivary amylase through a mechanism that does not involve capsaicin-sensitive nerves (Kawabata et al. 2002). There is no evidence that PAR-1 is involved in salivary epithelial function as selective PAR-1-activating peptides did not stimulate secretion (Kawabata et al. 2000b). The endogenous activator of salivary PAR-2 has not been identified.

Stomach - Both PAR-1 and PAR-2 have been shown to affect gastric mucosal function. Activation of PAR-1 appears to be cytoprotective in a gastric epithelial cell line (Toyoda et al. 2003) and in a rat model (Kawabata et al. 2004). In both studies, the protective effect was dependent upon cyclooxygenase activity. In contrast, other studies have shown that PAR-1 activation can cause plasma extravasation in the stomach (De Garavilla et al. 2001), suggestive of a pro-inflammatory effect of PAR-1. The difference may lie in the model used, with one being an assessment of the effect of PAR-1 activation on HCl-ethanol-induced damage in the rat (Kawabata et al. 2004) and one being an assessment of PAR-1 effects in normal mouse stomach (De Garavilla et al. 2001). The stimulation of plasma exudation by PAR-1 activation in the mouse is dependent upon sensory afferent nerves. Thus, the evidence to date suggests that epithelial PAR-1 may be protective in the stomach, through the stimulation of prostaglandin synthesis, whereas neuronal PAR-1 may promote neurogenic gastric mucosal inflammation.

PAR-2 activation has also been shown to be protective in the stomach. In this case, the effect may be to stimulate capsaicin-sensitive nerve-dependent release of calcitonin gene-related peptide and neurokinins and/or the stimulation of mucin secretion (Kawabata et al. 2001). Others have shown that activation of capsaicin-sensitive afferents in the stomach confers protection against injurious agents (Whittle et al. 1992, Morris et al. 1993).

In addition to their roles as a determinants of mucosal integrity, PAR-1 and PAR-2 have also been shown to stimulate pepsinogen secretion in the stomach (Fiorucci et al. 2003, Kawao et al. 2003). A clear mechanism for this secretory effect has yet to be elucidated, although in the case of PAR-2, its expression on chief cells suggests that the effect of activation may be direct (Kawao et al. 2002, Fiorucci et al. 2003).

Intestine - PARs have numerous effects on intestinal epithelial function. Indeed, one PARs may have several different effects depending upon the site of expression. For example, PAR-1 is expressed on both the basolateral and apical surfaces of SCBN, a duodenal crypt cell line. Activation of basolateral PAR-1 stimulates apically directed chloride secretion in a calcium-dependent manner (Buresi et al. 2001). This effect is due to a Src-kinase-associated epidermal growth factor receptor kinase transactivation which stimulates MAP kinase-induced activation of phospholipase A2. The subsequent liberation of arachidonic acid stimulates chloride secretion via a mechanism dependent upon both cyclooxygenase (COX)-1 and COX-2 (Buresi et al. 2002). In contrast, activation of apical PAR-1 in the same cell line activates a different signaling pathway, which is not Src-dependent, leading to apoptosis and increases in epithelial monolayer permeability (Chin et al. 2003). Since these results were obtained from a cell line, caution must be exercised when extrapolating the data to an integrated system like the whole intestine, but these studies clearly illustrate the point that polarity of PAR expression can have profound effects in terms of the cellular response.

PAR-2 is also expressed on intestinal epithelial cells (Kong et al. 1997, Green et al. 2000). Our preliminary data suggest that activation of epithelial PAR-2 also stimulates ion transport in cell line models (van der Merwe & MacNaughton, unpublished data). Activation of PAR-2 in isolated segments of rat jejunum stimulates chloride secretion in a manner independent of enteric nerves, suggesting that the effect is directly on the epithelium (Vergnolle et al. 1998). Similarly, PAR-2 activation of segments of human colon in vitro results in neurally independent chloride secretion (Mall et al. 2002).

While it is clear that PARs are expressed on the intestinal epithelia of several species, there is growing evidence that activation of PARs on other cell types can affect epithelial function. We have shown that PAR-1 is expressed on submucosal secretomotor neurons in mouse colon, and that its activation leads to the suppression of neurally evoked chloride secretion (Buresi et al. 2003). PAR-2 is also found on enteric nerves in pig (Green et al. 2000) and guinea pig (Reed et al. 2003) ileum. PAR-2 activation on enteric nerves may change the electrophysiological properties of these neurons, either causing excitation (Gao et al. 2002) or enhancing excitability by other activators (Reed et al. 2003).

In addition to enteric nerves, other cell types within the mucosal lamina propria can affect epithelial function. Subepithelial fibroblasts can respond to secretagogues with the production and release of secretory prostaglandins (Berschneider & Powell 1992). We have recently demonstrated that intestinal myofibroblasts of the type juxtaposed to secretory epithelia express PAR-1, and that PAR-1 activation leads to the expression of COX-2 and subsequent upregulation of PGE2 secretion (Seymour et al. 2003). Experiments to conclusively demonstrate that fibroblast PAR-1 stimulates chloride secretion have yet to be performed.

Mast cells express PAR-1 and PAR-2 (D'Andrea et al. 2000, Gordon et al. 2000), at least under some cir-cumstances. Mucosal mast cells in the intestine are an important source of mediators which can stimulate intestinal epithelial chloride secretion (McKay & Perdue 1993). While the effect of PAR activation on mast cell mediated secretion has not been investigated, the demonstration of such a relationship would have im-portant implications for mast cell-associated conditions such as intestinal anaphylaxis.

There has been increased interest in the role of PAR-2 as a mediator of neurogenic inflammation in the intestine (Steinhoff et al. 2000). Related to this is the recognition that PAR-2 can mediate hyperalgesia of the intestine (Coelho et al. 2002). Both of these situations point to a relationship between PAR-1 and capsaicin-sensitive afferent activation and indeed this relationship has been demonstrated experimentally (Steinhoff et al. 2000, De Garavilla et al. 2001, Vergnolle et al. 2001). We have evidence that capsaicin-sensitive extrinsic sensory afferent neurons can, through local axon reflexes, stimulate chloride secretion in guinea pig ileum in vitro (Vanner & MacNaughton 1995). More recent evidence implicates an interaction of the cannabinoid CB1 receptor and the capsaicin receptor, TRPV1 (MacNaughton et al. 2004). It is interesting to speculate that PAR-2 could modulate an interaction among the CB1 receptor and capsaicin-sensitive afferents in the regulation of intestinal epithelial secretory function.

Pancreas - In the pancreas, PAR-2 is expressed on both acinar cells (Kawabata et al. 2002) and duct epithelium (Nguyen et al. 1999), where its activation stimulates amylase secretion and electrolyte transport, respectively. Some forms of pancreatitis are characterized by premature activation of trypsinogen to trypsin, which activates PAR-2, suggesting that PAR-2 may play a role in pancreatic inflammation. Indeed, PAR-2 expression increases in the pancreas during a model of acute pancreatic lesion (Olejar et al. 2001). However, there is no direct evidence to implicate PAR-2 in the development of pancreatitis, either clinically or in animal models.

PARs, EPITHELIAL CELL PROLIFERATION AND CANCER

It has long been known that activation of PAR-1 and PAR-2 can stimulate second messenger pathways leading to cellular proliferation and differentiation (Dery et al. 1998). Substances which promote proliferation and differentiation are often associated with the potential to cause uncontrolled cellular growth. Recently, both PAR-1 and PAR-2 have been associated with the development of cancer in numerous models, including gastrointestinal epithelia. For example, abnormal PAR-1 expression is found in oral squamous cell carcinoma (Liu et al. 2001) and colon cancer cell lines (Darmoul et al. 2003). PAR-1 is also associated with tumour cell differentiation (Rudroff et al. 2002) and adhesion (Rudroff et al. 2001) in pancreatic cancer. PAR-1 appears to promote invasion signals in some cancer cells through activation of a Rho-A-dependent pathway (Nguyen et al. 2002).

Similarly, there is recent evidence linking PAR-2 with cancers of epithelial tissue in the gastrointestinal tract. In the colon, activation of PAR-2 leads to proliferation of several colonic epithelial cancer cell lines (Darmoul et al. 2001), which in the case of the DLD-1 colonic carcinoma cell line is mediated by a MEK-MAP kinase signal transduction pathway (Jikuhara et al. 2003). Likewise, PAR-2 has been implicated in cell proliferation, invasion and fibrosis in pancreatic cancer (Ikeda et al. 2003, Ohta et al. 2003, Shimamoto et al. 2004).

CONCLUSION

The wide distribution of PARs on gastrointestinal epithelia and on cells which affect epithelial function, along with the fact that gastrointestinal epithelia are exposed to serine proteinases under both physiological and pathophysiological conditions, suggests that PARs will be implicated as important modulators of health and disease in the gastrointestinal tract. Pathological conditions characterized by inflammation, abnormal secretion or uncontrolled proliferation may ultimately be shown to have a substantial component related to activation of PARs by serine proteinases. Advancing our knowledge of epithelial PARs will provide the impetus for the development of pharmacological agents to manipulate PARs to determine the course of diseases of the gut.

REFERENCES

  • Berschneider HM, Powell DW 1992. Fibroblasts modulate intestinal secretory responses to inflammatory mediators. J Clin Invest 89: 484-489.
  • Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, Bunnett NW 1996. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314: 1009-1016.
  • Buresi MC, Buret AG, Hollenberg MD, MacNaughton WK 2002. Activation of proteinase-activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase- and cyclo-oxygenase-dependent pathway. FASEB J 16: 1515-1525.
  • Buresi MC, Schleihauf E, Vergnolle N, Buret A, Wallace JL, Hollenberg MD, MacNaughton WK 2001. Protease-activated receptor-1 stimulates Ca(2+)-dependent Cl(-) secretion in human intestinal epithelial cells. Am J Physiol 281: G323-G332.
  • Buresi MC, Vergnolle N, Andrade-Gordon P, Hollenberg MD, Wallace JL, MacNaughton WK 2003. Activation of protease-activated receptor-1 (PAR-1) inhibits neurally evoked chloride secretion in the mouse colon. Gastroenterology 124: A342.
  • Chin AC, Vergnolle N, MacNaughton WK, Wallace JL, Hollenberg MD, Buret AG 2003. Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci USA 100: 11104-11109.
  • Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L 2002. Proteinases and proteinase-activated receptor 2: A possible role to promote visceral hyperalgesia in rats. Gastroenterology 122: 1035-1047.
  • Corvera CU, Déry O, McConalogue K, Böhm SK, Khitin LM, Caughey GH, Payan DG, Bunnett NW 1997. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor. J Clin Invest 100: 1383-1393.
  • Corvera CU, Dery O, McConalogue K, Gamp P, Thoma M, Al Ani B, Caughey GH, Hollenberg MD, Bunnett NW 1999. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol 517: 741-756.
  • D'Andrea MR, Rogahn CJ, Andrade-Gordon P 2000. Localization of protease-activated receptors-1 and -2 in human mast cells: indications for an amplified mast cell degranulation cascade. Biotech Histochem 75: 85-90.
  • Darmoul D, Gratio V, Devaud H, Lehy T, Laburthe M 2003. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162: 1503-1513.
  • Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M 2001. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 85: 772-779.
  • De Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P, Bunnett NW 2001. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 133: 975-987.
  • Dery O, Corvera CU, Steinhoff M, Bunnett NW 1998. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274: C1429-C1452.
  • Fiorucci S, Antonelli E, Distrutti E, Severino B, Fiorentina R, Baldoni M, Caliendo G, Santagada V, Morelli A, Cirino G 2004. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology 39: 365-375.
  • Fiorucci S, Distrutti E, Federici B, Palazzetti B, Baldoni M, Morelli A, Cirino G 2003. PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. Am J Physiol 285: G611-G620.
  • Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y, Wood JD 2002. Serine proteases excite myenteric neurons through prote-ase-activated receptors in guinea pig small intestine. Gastroenterology 123: 1554-1564.
  • Gordon JR, Zhang X, Stevenson K, Cosford K 2000. Thrombin induces IL-6 but not TNFalpha secretion by mouse mast cells: threshold-level thrombin receptor and very low level FcepsilonRI signaling synergistically enhance IL-6 secretion. Cell Immunol 205: 128-135.
  • Green BT, Bunnett NW, Kulkarni-Narla A, Steinhoff M, Brown DR 2000. Intestinal type 2 proteinase-activated receptors: expression in opioid- sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 295: 410-416.
  • Hollenberg MD, Compton SJ 2002. International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors. Pharmacol Rev 54: 203-217.
  • Ikeda O, Egami H, Ishiko T, Ishikawa S, Kamohara H, Hidaka H, Mita S, Ogawa M 2003. Expression of proteinase-activated receptor-2 in human pancreatic cancer: a possible relation to cancer invasion and induction of fibrosis. Int J Oncol 22: 295-300.
  • Jikuhara A, Yoshii M, Iwagaki H, Mori S, Nishibori M, Tanaka N 2003. MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. Life Sci 73: 2817-2829.
  • Kawabata A, Kinoshita M, Nishikawa H, Kuroda R, Nishida M, Araki H, Arizono N, Oda Y, Kakehi K 2001. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 107: 1443-1450.
  • Kawabata A, Kuroda R, Nishida M, Nagata N, Sakaguchi Y, Kawao N, Nishikawa H, Arizono N, Kawai K 2002. Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: Immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci 71: 2435-2446.
  • Kawabata A, Morimoto N, Nishikawa H, Kuroda R, Oda Y, Kakehi K 2000a. Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland. Biochem Biophys Res Commun 270: 298-302.
  • Kawabata A, Nishikawa H, Kuroda R, Kawai K, Hollenberg MD 2000b. Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol 129: 1808-1814.
  • Kawabata A, Nishikawa H, Saitoh H, Nakaya Y, Hiramatsu K, Kubo S, Nishida M, Kawao N, Kuroda R, Sekiguchi F, Kinoshita M, Kakehi K, Arizono N, Yamagishi H, Kawai K 2004. A protective role of protease-activated receptor 1 in rat gastric mucosa. Gastroenterology 126: 208-219.
  • Kawao N, Hiramatsu K, Inoi N, Kuroda R, Nishikawa H, Sekiguchi F, Kawabata A 2003. The PAR-1-activating peptide facilitates pepsinogen secretion in rats. Peptides 24: 1449-1451.
  • Kawao N, Sakaguchi Y, Tagome A, Kuroda R, Nishida S, Irimajiri K, Nishikawa H, Kawai K, Hollenberg MD, Kawabata A 2002. Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. Br J Pharmacol 135: 1292-1296.
  • Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK, Bunnett NW 1997. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 94: 8884-8889.
  • Liu Y, Gilcrease MZ, Henderson Y, Yuan XH, Clayman GL, Chen Z 2001. Expression of protease-activated receptor 1 in oral squamous cell carcinoma. Cancer Lett 169: 173-180.
  • Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R 2001. Proteinase-activated receptors. Pharmacol Rev 53: 245-282.
  • MacNaughton WK, van Sickle MD, Keenan CM, Cushing K, Mackie K, Sharkey KA 2004. Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. Am J Physiol 286: G863-G871.
  • Mall M, Gonska T, Thomas J, Hirtz S, Schreiber R, Kunzelmann K 2002. Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol 282: G200-G210.
  • McKay DM, Perdue MH 1993. Intestinal epithelial function: The case for immunophysiological regulation. Cells and mediators. Dig Dis Sci 38: 1377-1387.
  • Morris GP, Basu BK, Holitzner CA, Williamson TE 1993. Mucosal secretion and cytoprotection of the rat gastric mucosa. J Clin Gastroenterol 17 (Suppl. 1): S5-S10.
  • Mule F, Pizzuti R, Capparelli A, Vergnolle N 2004. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 53: 229-234.
  • Nguyen QD, Faivre S, Bruyneel E, Rivat C, Seto M, Endo T, Mareel M, Emami S, Gespach C 2002. RhoA- and RhoD-dependent regulatory switch of Ga subunit signaling by PAR-1 receptors in cellular invasion. FASEB J 16: 565-576.
  • Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, Bunnett NW 1999. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 103: 261-269.
  • Nystedt S, Larsson AK, Aberg H, Sundelin J 1995. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J Biol Chem 270: 5950-5955.
  • Ohta T, Shimizu K, Yi S, Takamura H, Amaya K, Kitagawa H, Kayahara M, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Miwa K 2003. Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. Int J Oncol 23: 61-66.
  • Olejar T, Matej R, Zadinova M, Pouckova P 2001. Expression of proteinase-activated receptor 2 during taurocholate-induced acute pancreatic lesion development in Wistar rats. Int J Gastrointest Cancer 30: 113-121.
  • Ossovskaya VS, Bunnett NW 2004. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621.
  • Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, Bunnett NW, Vanner SJ 2003. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 547: 531-542.
  • Rudroff C, Seibold S, Kaufmann R, Zetina CC, Reise K, Schafer U, Schneider A, Brockmann M, Scheele J, Neugebauer EA 2002. Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro. Clin Exp Metastasis 19: 181-189.
  • Rudroff C, Striegler S, Schilli M, Scheele J 2001. Thrombin enhances adhesion in pancreatic cancer in vitro through the activation of the thrombin receptor PAR 1. Eur J Surg Oncol 27: 472-476.
  • Seymour ML, Zaidi NF, Hollenberg MD, MacNaughton WK 2003. PAR1-dependent and independent increases in COX-2 and PGE2 in human colonic myofibroblasts stimulated by thrombin. Am J Physiol 284: C1185-C1192.
  • Shimamoto R, Sawada T, Uchima Y, Inoue M, Kimura K, Yamashita Y, Yamada N, Nishihara T, Ohira M, Hirakawa K 2004. A role for protease-activated receptor-2 in pancreatic cancer cell proliferation. Int J Oncol 24: 1401-1406.
  • Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, Bunnett NW 2000. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6: 151-158.
  • Toyoda N, Gabazza EC, Inoue H, Araki K, Nakashima S, Oka S, Taguchi Y, Nakamura M, Suzuki Y, Taguchi O, Imoto I, Suzuki K, Adachi Y 2003. Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells. Scand J Gastroenterol 38: 253-259.
  • Vanner S, MacNaughton WK 1995. Capsaicin-sensitive afferent nerves activate submucosal secretomotor neurons in guinea pig ileum. Am J Physiol 269: G203-G209.
  • Vergnolle N, MacNaughton WK, Al Ani B, Saifeddine M, Wallace JL, Hollenberg MD 1998. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 95: 7766-7771.
  • Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD 2001. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22: 146-152.
  • Whittle BJR, Lopez-Belmonte J, Moncada S 1992. Nitric oxide mediates rat mucosal vasodilatation induced by intragastric capsaicin. Eur J Pharmacol 218: 339-341.

Copyright 2005 Instituto Oswaldo Cruz - Fiocruz

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2019, Site last up-dated on 15-Ago-2019.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil